☰

Kelly Flentie, Ph.D. - Publications

Affiliations: 
2011 Biology & Biomedical Sciences (Molecular Microbiology & Microbial Pathogenesis) Washington University, Saint Louis, St. Louis, MO 
Area:
Microbiology Biology
Tree Info Grants Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Flentie K, Gonzalez C, Kocher B, Wang Y, Zhu H, Marasa J, Piwnica-Worms D. Nucleoside Diphosphate Kinase-3 (NME3) Enhances TLR5-Induced NF-κB Activation. Molecular Cancer Research : McR. PMID 29523766 DOI: 10.1158/1541-7786.Mcr-17-0603  0.555
2017 Syal K, Flentie K, Bhardwaj N, Maiti K, Jayaraman N, Stallings CL, Chatterji D. Synthetic (p)ppGpp analogue: Inhibitor of stringent response in mycobacteria. Antimicrobial Agents and Chemotherapy. PMID 28396544 DOI: 10.1128/Aac.00443-17  0.318
2016 Mann KM, Pride A, Flentie K, Kimmey J, Weiss L, Stallings C. Analysis of the contribution of MTP and the predicted Flp pilus genes to Mycobacterium tuberculosis pathogenesis. Microbiology (Reading, England). PMID 27586540 DOI: 10.1099/Mic.0.000368  0.36
2016 Flentie K, Garner AL, Stallings CL. The Mycobacterium tuberculosis transcription machinery: ready to respond to host attacks. Journal of Bacteriology. PMID 26883824 DOI: 10.1128/Jb.00935-15  0.356
2016 Gonzalez C, Flentie K, Kocher B, Marasa JJ, Piwnica-Worms D. Abstract 4880: A high-throughput siRNA screen identifies Nucleoside Diphosphate Kinase (NME3) as a novel host regulator of NF-êB signaling in response toSalmonella-induced activation of TLR-5 Cancer Research. 76: 4880-4880. DOI: 10.1158/1538-7445.Am2016-4880  0.573
2012 Flentie K, Kocher B, Gammon ST, Novack DV, McKinney JS, Piwnica-Worms D. A bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapy. Cancer Discovery. 2: 624-37. PMID 22728436 DOI: 10.1158/2159-8290.Cd-11-0201  0.616
2012 Kocher BA, Flentie K, Piwnica-Worms D. Abstract LB-367: Bioluminescent transposon screen identifies cancer cell specific promoters in Salmonella typhimurium Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-367  0.458
2009 Dothager RS, Flentie K, Moss B, Pan MH, Kesarwala A, Piwnica-Worms D. Advances in bioluminescence imaging of live animal models. Current Opinion in Biotechnology. 20: 45-53. PMID 19233638 DOI: 10.1016/J.Copbio.2009.01.007  0.483
2008 Flentie KN, Qi M, Gammon ST, Razia Y, Lui F, Marpegan L, Manglik A, Piwnica-Worms D, McKinney JS. Stably integrated luxCDABE for assessment of Salmonella invasion kinetics. Molecular Imaging. 7: 222-33. PMID 19123992 DOI: 10.2310/7290.2008.00024  0.622
2008 Terry CM, Picking WL, Birket SE, Flentie K, Hoffman BM, Barker JR, Picking WD. The C-terminus of IpaC is required for effector activities related to Shigella invasion of host cells. Microbial Pathogenesis. 45: 282-9. PMID 18656530 DOI: 10.1016/J.Micpath.2008.06.003  0.369
Show low-probability matches.